; and (B) ensuring the family of such child is— (i) provided comprehensive, consumer-oriented information about the full range of family support, training, information services, and language acquisition in oral and visual modalities; and (ii) given the opportunity to consider and obtain the full range of such appropriate services, educational and program placements, and other options for the child from highly qualified providers. (3) The term medical evaluation means key components performed by a physician, including history, examination, and medical decisionmaking focused on symptomatic and related body systems for the purpose of diagnosing the etiology of hearing loss and related physical conditions, and for identifying appropriate treatment and referral options. (4) The term medical intervention means the process by which a physician provides medical diagnosis and direction for medical or surgical treatment options for hearing loss or other medical disorders associated with hearing loss. (5) The term newborn, infant, and young childhood hearing screening means objective physiologic procedures to detect possible hearing loss and to identify newborns, infants, and young children up to the age of three who require further audiologic evaluations and medical evaluations. (f) Authorization of appropriations (1) Statewide newborn, infant, and young childhood hearing screening, evaluation and intervention programs and systems For the purpose of carrying out subsection (a), there are authorized to be appropriated to the Health Resources and Services Administration $17,800,000 for each of fiscal years 2018 through 2022. (2) Technical assistance, data management, and applied research; Centers for Disease Control and Prevention For the purpose of carrying out subsection (b)(1), there are authorized to be appropriated to the Centers for Disease Control and Prevention $10,800,000 for each of fiscal years 2018 through 2022. (3) Technical assistance, data management, and applied research